Ibiflo S 50/500 MG Nexcap 30 is primarily utilised to manage chronic obstructive pulmonary disease (COPD) and asthma in adults. This medication is a combination of two active ingredients and is classified as a corticosteroid and a long-acting beta-2 agonist.
In addition to its primary use, this medicine is indicated for the maintenance treatment of airflow obstruction and for the prevention of exacerbations in patients with COPD, which includes chronic bronchitis and emphysema. It is also employed in the long-term, twice-daily maintenance treatment of asthma in patients aged four and above.
This medicine should be taken orally as directed by your doctor. Ensure you inform your doctor about any pre-existing conditions or ongoing medications before starting this medicine. If you notice any side effects while on this medicine, notify your doctor immediately. Continue taking the medicine for the period prescribed by your doctor for optimal results.